Second generation drug-eluting stents are safe and effective in treatment of left main coronary artery disease
A study found that second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions. Results of the ISAR-LEFT MAIN 2 trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Patients undergoing invasive treatment of unprotected left main coronary artery (uLMCA) lesions are often considered at high-risk of adverse cardiovascular events. The use of first generation drug-eluting stents in these lesions has previously been shown to be feasible, safe, and effective. The second-generation zotarolimus-eluting (ZES) and everolimus-eluting stents (EES), used more widely in clinical practice at present, perform very similarly in nearly all coronary artery lesions. However, their performance in uLMCA lesions has not yet been assessed.
The ISAR-LEFT MAIN 2 trial is the first and largest performed randomized, multicenter comparison trial between ZES and EES in uLMCA lesions. The study was designed to assess the non-inferiority of ZES to EES regarding the primary end-point: incidence of major adverse cardiac events (MACE), which was defined as the composite of death, myocardial infarction or target lesion revascularization at one-year follow-up. Secondary endpoints included the incidence of definite/probable stent thrombosis at one-year follow-up and angiographic restenosis at six-nine month follow-up.
In total, 650 patients with ischemic symptoms or evidence of myocardial ischemia in the presence of at least one ≥ 50 percent de novo stenosis located in the LMCA who were unable or unwilling to undergo surgery were randomly assigned to receive ZES (n= 324) or EES (n=326).
The incidence of MACE was 17.5 percent in the ZES group and 14.3 percent in the EES group (p=0.25). The incidence of definite stent thrombosis was 0.6 percent in both groups, while probable stent thrombosis occurred in 0.3 percent of the ZES group and 0 percent of the EES group. Angiographic restenosis occurred in 21.5 percent of the ZES group and 16.8 percent of the EES group.
"Results of this trial indicate that the use of second generation drug-eluting stents in unprotected left main coronary artery lesions in relatively unselected patients is feasible, safe and effective," said lead investigator, Julinda Mehilli, MD. Prof. Dr. Mehilli is Director of Catheterization Laboratories at the Medizinische Klinik I, Klinikum der Universitaet Munich and Co-Director of Clinical Research and Data Coordinating in the Intracoronary Stenting and Antithrombosis Research (ISAR) Center at the German Heart Center in Munich.
"Both zotarolimus and everolimus stents provide similar clinical and angiographic outcomes at one-year follow-up in this high-risk patient population," said Dr. Mehilli.
Provided by Cardiovascular Research Foundation
- Researchers find drug-eluting stents safe, effective for PCI in diabetics Sep 21, 2009 | not rated yet | 0
- Clinical outcomes in PCI patients given sirolimus-eluting and everolimus-eluting stents Aug 29, 2011 | not rated yet | 0
- Drug-Eluting stents reduce risk of thrombosis Mar 23, 2012 | not rated yet | 0
- Study finds everolimus-eluting stent safer, more effective than paclitaxel-eluting stent May 05, 2010 | not rated yet | 0
- Low and comparable rates of stent thrombosis found with zotarolimus- and sirolimus-eluting stents Aug 27, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Is this plasma (picture in thread)
31 minutes ago http://postimg.org/image/d530nwobf/
Basic physics understanding. Could someone explain?
2 hours ago I'm trying to get a grip on some classic physics by watching a Stanford lecture. I've made it through the first one, and now in the second one all...
Change in flux of a transformer
3 hours ago Hello, As I understand, a simple transformer works by using the Input AC in the primary coil to generate magnetic field in the iron core, which...
Electric field between parallel plate capacitor
3 hours ago If you have an infinite non-conducting plate, the electric field just outside is equal to sigma / 2*epsilon. The electric field just outside a...
Why angle of projectile has 2 solutions?
4 hours ago I have the final answer of: sin2(theta) = 0.871 why does (theta) = 30.3 deg OR (theta) = 59.7 deg I get why this could be physically, but...
How much negative charge do I accumulate by touching the earth?
5 hours ago The Earth carries a negative electric charge of roughly 500 thousand Coulombs (according to different sources I've seen). If I touch the Earth I...
- More from Physics Forums - Classical Physics
More news stories
Transcatheter aortic valve implantation (TAVI) is effective and safe in Asian patients, according to early experience based on first results from a multicentre Asian registry reported at EuroPCR 2013.
Cardiology 6 hours ago | not rated yet | 0
Routinely measuring fractional flow reserve (FFR) using pressure wire assessment during coronary angiography for diagnosis of chest pain leads to significant changes in the management of one in four patients, according to ...
Cardiology 9 hours ago | not rated yet | 0
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of ...
Cardiology 9 hours ago | not rated yet | 0
Cardiac study used as source for new guidelines on treating people undergoing coronary artery bypass surgery
Cardiac research from the University of Alberta had serious impact as a source for the American College of Cardiology and the American Heart Association's new guidelines on how to treat patients undergoing coronary artery ...
Cardiology 10 hours ago | not rated yet | 0
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Cardiology 23 hours ago | not rated yet | 0
9 hours ago | 5 / 5 (3) | 0 |
6 hours ago | 5 / 5 (1) | 0 |
6 hours ago | 5 / 5 (2) | 0 |
3 hours ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...
10 hours ago | not rated yet | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
2 hours ago | not rated yet | 0